Physician

Frederick Herbert Weidman, MD

According to 2025 Medicare claims, Frederick Weidman, MD (NPI: 1730179102) practices ophthalmology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is HORIZON EYE CARE, PA (NPI: 1235192113; TIN: 56-2052180) and primary practice location at 28211-3870.

Weidman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 989 traditional Medicare patients, billed 47,716 HCPCS/CPT codes, and received $2,972,765 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 968 prescription claims across 276 beneficiaries totaling $119,817 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 24 records totaling $782. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $2,827,841 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,799,295 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,646,986 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,649,004 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,540,673 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,368,430 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,451,024 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,378,528 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,312,880 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,972,765 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,21614,631$2,827,841
20161,22814,367$2,799,295
20171,19114,343$2,646,986
20181,16215,044$2,649,004
20191,10214,159$2,540,673
20201,00312,685$2,368,430
20211,07713,205$2,451,024
20221,07417,987$2,378,528
20231,04939,029$2,312,880
202498947,716$2,972,765

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$60K$120K2015 Drug cost: $113,038 (USD; Tot_Drug_Cst)2016 Drug cost: $111,236 (USD; Tot_Drug_Cst)2017 Drug cost: $96,669 (USD; Tot_Drug_Cst)2018 Drug cost: $116,081 (USD; Tot_Drug_Cst)2019 Drug cost: $114,975 (USD; Tot_Drug_Cst)2020 Drug cost: $93,595 (USD; Tot_Drug_Cst)2021 Drug cost: $94,333 (USD; Tot_Drug_Cst)2022 Drug cost: $110,115 (USD; Tot_Drug_Cst)2023 Drug cost: $96,227 (USD; Tot_Drug_Cst)2024 Drug cost: $119,817 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015250997$113,038
2016248884$111,236
2017230846$96,669
20182621,053$116,081
20192401,034$114,975
2020232771$93,595
2021227777$94,333
2022251842$110,115
2023249892$96,227
2024276968$119,817

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2741,493$87
92014Established patient complete exam of visual system9292,430$82
92134Imaging of retina8742,354$28
92250Photography of the retina159188$24
92201Extended exam of the back part of the eye with retinal drawing133143$15

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine13870$17,734
Prednisolone AcetatePrednisolone Acetate34113,925$16,170
ProlensaBromfenac Sodium311,168$10,210
Ketorolac TromethamineKetorolac Tromethamine1174,900$3,972
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol311,632$3,533

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$782ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$4,630US Retina LLC

FAQ

What Medicare data is available for Frederick Herbert Weidman, MD?

Tedicare shows public-source Medicare data for Frederick Herbert Weidman, MD (NPI 1730179102), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Frederick Herbert Weidman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Frederick Herbert Weidman, MD?

Frederick Herbert Weidman, MD is linked to HORIZON EYE CARE, PA (billing NPI 1235192113) in the available physician profile data.

Does Frederick Herbert Weidman, MD have Open Payments data?

Frederick Herbert Weidman, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.